Retour
34
2
Fourchette du Jour
18,17 €
20,43 €
Fourchette 52 Semaines
14,09 €
21,22 €
Volume
24
Moyenne 50J / 200J
18,17 €
/
19,03 €
Clôture Précédente
18,17 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 0,1 | 0,3 |
| P/B | 0,0 | 2,9 |
| ROE % | 10,6 | 3,7 |
| Net Margin % | 5,2 | 3,8 |
| Rev Growth 5Y % | 17,5 | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
195,59 €
191,17 € – 199,53 €
|
1300 B | 1 |
| FY2029 |
185,85 €
181,64 € – 189,59 €
|
1200 B | 1 |
| FY2028 |
162,15 €
158,48 € – 165,42 €
|
1200 B | 1 |
Points Clés
Revenue grew 17,50% annually over 5 years — strong growth
ROE of 10,56% — decent returns on equity
Debt/Equity of 0,00 — conservative balance sheet
Generating 67,01B in free cash flow
P/E of 0,13 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 13,68%
Croissance
Revenue Growth (5Y)
17,50%
Revenue (1Y)3,82%
Earnings (1Y)4,45%
FCF Growth (3Y)19,01%
Qualité
Return on Equity
10,56%
ROIC11,77%
Net Margin5,15%
Op. Margin7,73%
Sécurité
Debt / Equity
0,00
Current Ratio2,24
Interest Coverage1282,53
Valorisation
P/E Ratio
0,13
P/B Ratio0,01
EV/EBITDA-1,25
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3,82% | Revenue Growth (3Y) | 5,64% |
| Earnings Growth (1Y) | 4,45% | Earnings Growth (3Y) | 16,13% |
| Revenue Growth (5Y) | 17,50% | Earnings Growth (5Y) | 26,13% |
| Profitability | |||
| Revenue (TTM) | 1,06T | Net Income (TTM) | 54,68B |
| ROE | 10,56% | ROA | 7,67% |
| Gross Margin | 35,06% | Operating Margin | 7,73% |
| Net Margin | 5,15% | Free Cash Flow (TTM) | 67,01B |
| ROIC | 11,77% | FCF Growth (3Y) | 19,01% |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 2,24 |
| Interest Coverage | 1282,53 | Dividend Yield | 0,02% |
| Valuation | |||
| P/E Ratio | 0,13 | P/B Ratio | 0,01 |
| P/S Ratio | 0,01 | PEG Ratio | 2,32 |
| EV/EBITDA | -1,25 | Dividend Yield | 0,02% |
| Market Cap | 7,23B | Enterprise Value | -102,31B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,06T | 1,02T | 951,25B | 729,97B | 556,91B |
| Net Income | 54,68B | 52,35B | 40,55B | 34,38B | 21,60B |
| EPS (Diluted) | 133,81 | 125,27 | 95,99 | 93,78 | 70,12 |
| Gross Profit | 372,24B | 331,80B | 329,32B | 240,30B | 182,10B |
| Operating Income | 82,08B | 75,71B | 62,28B | 41,41B | 31,53B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 712,78B | 724,75B | 688,13B | 656,74B | 368,92B |
| Total Liabilities | 191,28B | 209,57B | 205,42B | 192,40B | 122,46B |
| Shareholders' Equity | 520,80B | 514,73B | 482,47B | 464,32B | 246,46B |
| Total Debt | 2,21B | 20,66B | 21,41B | 22,92B | 23,70B |
| Cash & Equivalents | 111,75B | 117,72B | 95,22B | 74,52B | 38,52B |
| Current Assets | 364,32B | 370,80B | 329,81B | 304,39B | 175,70B |
| Current Liabilities | 162,64B | 179,43B | 153,27B | 142,45B | 84,89B |
Scores de Stratégies
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
#581 of 827
#683 of 709
Activité Récente
Entré
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entré
Defensive Investing (Benjamin Graham)
Mar 24, 2026